1 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 2 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Tinnitus, Bilateral: new trials by email Literature Review of Tinnitus, Bilateral trials Research Report on Tinnitus, Bilateral
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Testing Safety and Efficacy of Transtympanic Paliroden for the Treatment of Cochlear Synaptopathy in Participants With Chronic, Constant Tinnitus paliroden (CIL001), Placebo - Tinnitus, Bilateral, Cochlear Synaptopathy | Phase 1 / Phase 2 | Not yet recruiting | Cilcare SAS | 60 | 2027-01-01 | 2026-09-17 |
| Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Tinnitus DeepTms - Tinnitus, Tinnitus, Bilateral | Not applicable | Recruiting | University of Regensburg | 60 | 2026-09-19 | 2026-10-21 |
| Tinnitus Patient Preferences Survey Survey using a questionnaire. - Tinnitus, Subjective, Tinnitus, Bilateral | Completed | Nicolas Gninenko | 1000 | 2025-01-13 | 2026-09-09 | |
| Effect of Combined Antioxidant Therapy on Oxidative Stress Markers and Inflammatory Cytokines in Patients With Tinnitus Drusen Mega®, Sertraline, Placebo - Tinnitus, Subjective, Tinnitus, Bilateral | Phase 2 | Unknown | University of Guadalajara | 58 | 2022-12-01 | 2023-04-07 |
Tinnitus (4) · Hearing Loss (1) · Hearing Loss, Hidden (1) · Patient Preference (1)
Ear Diseases (4) · Hearing Disorders (4) · Nervous System Diseases (4) · Neurologic Manifestations (4) · Otorhinolaryngologic Diseases (4) · Pathological Conditions, Signs and Symptoms (4) · Sensation Disorders (4) · Signs and Symptoms (4) · Behavior (1) · Health Behavior (1) · Hearing Loss (1) · Patient Satisfaction (1) · Treatment Adherence and Compliance (1)
Geritol (1) · Magnesium Oxide (1) · Sertraline (1)
Cilcare SAS (1) · Nicolas Gninenko (1) · University of Guadalajara (1) · University of Regensburg (1)
Germany (1) · Mexico (1) · United States (1)
Nicolas Gninenko, PhD (1) · Stefan Schoisswohl, Prof. Dr. hum sc (1)